Clinical Trials in Austin

Showing 5461-5480 of 11,561 trials

42-Day Repeat Oral Dose Study of AKB-6548 in Participants With Chronic Kidney Disease and Anemia

NCT01381094

The purpose of this study is to evaluate the dose response (efficacy), pharmacodynamic response, pharmacokinetics, safety, and tolerability of orally administered AKB-6548 in pre-dialysis participants with anemia with repeat dosing for 42 days.

AnemiaKidney Disease

Akebia Therapeutics93 participantsStarted Jun 2011

Pine Bluff, Arkansas, United States • Covina, California, United States • Los Angeles, California, United States +25 more locations

TERMINATEDPhase 3< 1 mile

Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids (ASTEROID 4)

NCT03400956

The primary objective of this study was to show superiority of vilaprisan in the treatment of heavy menstrual bleeding (HMB) in subjects with uterine fibroids compared to placebo The secondary objectives of this study were to additionally evaluate the efficacy and safety of vilaprisan in subjects with uterine fibroids

Uterine Fibroids

Bayer103 participantsStarted Jan 2018

Canyon Country, California, United States • Encinitas, California, United States • Huntington Park, California, United States +84 more locations

42-Day Repeat Oral Dose Study of AKB-6548 in Participants With Chronic Kidney Disease and Anemia

Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids (ASTEROID 4)

Find Trials by Condition in Austin

Safety Study of the VEGA UV-A System to Treat Ectasia

Safety and Effectiveness Study of the VEGA UV-A System for Cross-linking in Eyes With Keratoconus and Ectasia

SHIELD II Clinical Investigation

Prevention of Non-Surgical Bleeding by Management of HeartMate II Patients Without Antiplatelet Therapy

Study to Evaluate Vadadustat for the Correction of Anemia in Participants With Non-dialysis-dependent Chronic Kidney Disease

Safety and Efficacy Study for AKB-6548 in Participants With Chronic Kidney Disease and Anemia

Study of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalized Patients

MOMENTUM 3 IDE Clinical Study Protocol

Thoratec HeartMate II Left Ventricular Assist System (LVAS) for Bridge to Cardiac Transplantation

CentriMag Ventricular Assist System in Treating Failure-to-Wean From Cardiopulmonary Bypass

Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device (LVAD) and Medical Management

Long-term Study of Romiplostim in Thrombocytopenic Pediatric Patients With Immune Thrombocytopenia (ITP)

Study of Nab-Paclitaxel and Ramucirumab as Second-line Treatment for Patients With Metastatic Gastroesophageal Cancer

Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects

Esteem New Subject Enrollment Post Approval Study

Cooled RFA vs Conventional RFA to Manage Chronic Facetogenic Low Back Pain

A Study of Two Different Dose Combinations of Nivolumab in Combination With Ipilimumab in Subjects With Previously Untreated, Unresectable or Metastatic Melanoma

Study of Reduced Anti-coagulation/Anti-platelet Therapy in Patients With the HeartMate II Left Ventricular Assist System (LVAS) (TRACE)